Pfizer’s US Contract Sets The Financial Bar For COVID-19 Vaccines

The US government’s order of 100 million doses for $1.95bn means the implied price for Pfizer/BioNtech's vaccine is $19.50 per dose. That could set a benchmark for solid near-term revenue and profitability for companies in the space. 

profit text written on wooden block with stacked coins on grey background
Pfizer's appears poised to make a solid profit off of a COVID-19 vaccine • Source: Shutterstock

More from COVID-19

More from Scrip